Antisense Therapeutics Limited

Antisense Therapeutics Limited focuses its clinical research activity on Duchenne Muscular Dystrophy, with attention to the functional limitations experienced by non-ambulant participants and the preservation of upper limb muscle function. The sponsor’s work is centred on the clinical burden of progressive muscle weakness and loss of motor ability in this rare neuromuscular condition.

• Non-ambulant DMD
• Upper limb function
• Muscle performance

Its research interest includes outcomes relevant to day-to-day physical function in advanced Duchenne Muscular Dystrophy, particularly measures used to track changes in limb strength and mobility-related capability.